The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|4|4|340-356

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.4, Iss.4, 2008-11, pp. : 340-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Resistance, Impaired Postprandial Lipid Metabolism and Abdominal Obesity

By  

Medical Principles and Practice, Vol. 11, Iss. 2, 2002-11 ,pp. : 31-40

Karger

Access to resources Recommend Favorite

Zinc balance and medications commonly used in the management of heart failure

By Cohen Natan   Golik Ahuva  

Heart Failure Reviews, Vol. 11, Iss. 1, 2006-03 ,pp. : 19-24

Springer Publishing Company

Access to resources Recommend Favorite

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

By Bajaj M.   Suraamornkul S.   Hardies L.   Glass L.   Musi N.   DeFronzo R.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1723-1731

Springer Publishing Company

Access to resources Recommend Favorite

Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Obesity in Patients with Type 2 Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite